1. Home
  2. ACET vs JRSH Comparison

ACET vs JRSH Comparison

Compare ACET & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

SELL

Current Price

$6.37

Market Cap

83.3M

Sector

Health Care

ML Signal

SELL

Logo Jerash Holdings (US) Inc.

JRSH

Jerash Holdings (US) Inc.

HOLD

Current Price

$6.05

Market Cap

68.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACET
JRSH
Founded
1947
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
68.8M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
ACET
JRSH
Price
$6.37
$6.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
★ $34.83
$6.50
AVG Volume (30 Days)
★ 272.2K
87.1K
Earning Date
11-04-2026
11-11-2026
Dividend Yield
N/A
★ 3.32%
EPS Growth
N/A
★ 485.71
EPS
N/A
★ 0.13
Revenue
N/A
★ $166,263,870.00
Revenue This Year
N/A
$14.07
Revenue Next Year
N/A
$7.46
P/E Ratio
★ N/A
$46.38
Revenue Growth
N/A
★ 14.03
52 Week Low
$0.46
$2.85
52 Week High
$9.97
$6.07

Technical Indicators

Market Signals
Indicator
ACET
JRSH
Relative Strength Index (RSI) 34.28 65.44
Support Level N/A $3.11
Resistance Level $8.85 N/A
Average True Range (ATR) 0.69 0.22
MACD -0.28 0.03
Stochastic Oscillator 3.45 84.90

Price Performance

Historical Comparison
ACET
JRSH

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

Share on Social Networks: